Acomplia (Rimonabant) is a weight loss drug that works by blocking the CB1 receptor, which stimulates hunger and other cravings in the brain and is also present in fat tissue. Acomplia (Rimonabant) helps in controlling food cravings gradually resulting in weight loss, improvement of cardiovascular/metabolic risk factors in obese patients and helps to reduce tobacco dependence without post cessation weight gain in people who smoke. This is found in the Endocannabinoid system (EC system) which plays a role in the regulation of food intake and energy expenditure of our body. Acomplia (Rimonabant) is a prescription drug to be taken as an adjunct to diet and exercise. In adults, the recommended dosage of Acomplia (Rimonabant) is 20mg daily to be taken in the morning before breakfast. The treatment should be introduced with a mildly reduced calorie diet. Children should not be taking this medication. Acomplia (Rimonabant) is metabolized by the liver, thus caution is advised in patients with moderate hepatic impairment. Acomplia (Rimonabant) should not be used in patients with severe renal impairment. Acomplia (Rimonabant) should be used with caution.

Acomplia (Rimonabant) is a multifunctional pill and helps in quit smoking along with weight reduction, has some side effects which are very minor and that usually only stay for the first year. Acomplia (Rimonabant) side effects appear when its used for the first time and are likely to disappear as soon as the body becomes used to it. Acomplia (Rimonabant) side effects include depression, anxiety, nausea, and irritability. Side effects appear to be fewer and less severe than those of many other weight loss medications on the market. Acomplia (Rimonabant) is immensely beneficial for its users due to the positive effects of weight loss and its apparent ability to maintain healthy blood pressure, blood sugar and cholesterol level.